Indose, a Woodland Hills, California-based provider of a precise dosage vaporizer, closed a $3.5m Series A funding.
The round was led by Casa Verde Capital.
The company intends to use the funds to expand partnerships with cannabis oil manufacturers and brands across the country, increase the size of the R&D team, file for additional patents, and pursue medical device certification.
Co-founded by tech entrepreneur and Farmigo CEO Benzi Ronen and brothers Ari and Dani Freeman, Indose brings to market a proprietary metered vape pen technology that measures the precise dose —down to the milligram — of THC delivered with every draw. As a person inhales, their dosage is shown in real-time on an LED display that ranges from .05 MG to 4 MG, creating an individualized, controlled cannabis vaping experience.
Following three years of research and development (and 15 filed patents), the Indose vaporizer features two proprietary sensors which take 10 measurements per second to calculate the precise milligrams of THC and CBD being inhaled by the user. This dosage is presented on the device in real time via an easy to read LED display. It allows users to micro-dose in .05 MG increments.
The vaporizer, which retails for less than $70, is recyclable and currently available in select pilot dispensaries in California. It will announce a large-scale distribution partnership this summer.